tirzepatide surmount 4 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial SURMOUNT‐4 study design. This is

The rise in obesity rates growth contribution during the forecast period in 2025 is 4.5%

The challenge is dealing with the hunger and cravings that can disrupt your momentum and leave you starting over every Monday

Dahl D, Onishi Y, Norwood P et al (2022) Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial

Can it be used with Minoxidil or PRP

Ozempic (lower-dose semaglutide) If you're using Ozempic for diabetes (typically 0.5-1.0 mg weekly), you're less likely to experience fatigue

Baseline lab work should include at minimum fasting glucose, HbA1c, lipid panel, comprehensive metabolic panel, and thyroid function